> | KB | > | Results |
Scope
Pharmaceuticals
Transit and Contained Use
Application of the Advance Informed Agreement Procedure
Notification
Acknowledgement of Receipt of Notification
Decision Procedure
Procedure for Living Modified Organisms Intended for Direct Use as Food or Feed, Or For Processing
Review of Decisions
Simplified Procedure
Bilateral and Multilateral Agreements and Arrangements
Risk Assessment
Risk Management
Unintentional Transboundary Movements and Emergency Measures
Handling, Transport, Packaging and Identification
Competent National Authorities and National Focal Points
Information Sharing and the Biosafety Clearing-House
Confidential Information
Capacity-Building
Public Awareness and Participation
Non-Parties
Illegal Transboundary Movements
Socio-Economic Considerations
Liability and Redress
Financial Mechanism and Resources
Conference of the Parties Serving as the Meeting of the Parties to this Protocol
Subsidiary Bodies
Secretariat
Relationship With the Convention
Monitoring and Reporting
Compliance
Assessment and Review
Signature
Entry Into Force
Reservations
Withdrawal
Authentic Texts
Information Required in Notifications Under Article 8, 10 and 13
Information Required Concerning Living Modified Organisms Intended for Direct Use as Food or Feed, or for Processing Under Article 11
Risk Assessment
Preamble
Objective
Use of Terms
Scope
Relationshop with International Agreements and Instruments
Fair and Equitable Benefit-Sharing
Access to Genetic Resources
Access to Traditional Knowledge Associated with Genetic Resources
Special Considerations
Contribution to Conservation and Sustainable Use